
There is a quiet assumption running through a lot of AI-era sales writing: that qualification frameworks were a workaround for not having enough data, and now that we have the data, we can skip them.
This is backwards. The tooling has made it dramatically easier to generate activity and no easier at all to know whether a deal is real. If anything, the gap between those two things has widened, and qualification is the only thing that closes it.
What the tools actually solved
They solved research. Finding the account, understanding the business, identifying who to contact, drafting something relevant: all of that used to be most of the job and now takes minutes.
They solved admin. Call notes, CRM hygiene, follow-up drafting, pipeline reporting. Real hours, genuinely returned.
They solved the blank page. Nobody starts from nothing now.
That is a lot. It is also entirely upstream of the thing that determines whether you hit your number.
What they did not solve
Whether this person can actually sign. Whether there is budget this year or just enthusiasm. What happens internally between your champion saying yes and money moving. Whether the problem you solve is on anybody's list of things that must be fixed before December.
No model knows these things, because they are not written down anywhere. They live in the heads of people inside the account, and the only way to extract them is to ask, carefully, in a conversation, repeatedly.
That is what MEDDIC is. Not a form to fill in. A list of the things you will wish you had asked, in the month when the deal you forecast does not close.
The failure mode I see most
A team adopts a good modern stack. Pipeline creation goes up substantially. Everyone is pleased. Two quarters later, conversion has fallen, cycle length has stretched, and the forecast has become fiction.
What happened is that the stack made it cheap to open conversations and nothing made it harder to keep bad ones alive. The pipeline filled with deals that felt warm, had an engaged contact, and no path to a signature. Nobody disqualified anything because disqualifying is unpleasant and the dashboard looked excellent.
More activity with the same qualification discipline gives you more revenue. More activity with less discipline gives you a busier team and a worse quarter.
Where the tools genuinely help qualification
They are good at the part of MEDDIC that is research rather than judgement.

Metrics: pulling public financials, headcount trends, earnings commentary to work out what the business is actually measured on.
Decision process: mapping the org, finding who reports to whom, spotting who has signed similar things before.
Competition: knowing what they already run, and what switching would cost them.
Use them for that and the conversations get sharper. The conversations still have to happen.
The practical version
If you take one thing from this: write down, for every deal above whatever threshold matters to you, who signs it and what has to be true for them to sign it this quarter. If you cannot answer both, it is not a deal yet. It is a conversation.
That is not a framework. It is two questions, and most pipelines would be half the size and twice as accurate if teams asked them honestly.
The rigour was never the inefficient part of selling. The research was, and that problem is now solved. Keep the rigour.
Pipeline looks healthy but the forecast keeps missing? Start with a GTM diagnostic.